mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.8 |